Publicaties
Role of glycosylation in the immunogenicity of the nematode specific activation-associated secreted proteins (ASPs) and its implication in vaccine efficacy Universiteit Gent
To treat or not to treat : diagnostic thresholds in subclinical helminth infections of cattle Universiteit Gent
Ascaridia galli : an old problem that requires new solutions Universiteit Gent
Benzimidazole resistance in cattle : the first report of the presence of F200Y mutation in cooperia in Ecuador Universiteit Gent
World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guideline for diagnosing anthelmintic resistance using the faecal egg count reduction test in ruminants, horses and swine Universiteit Gent
Understanding the uptake of diagnostics for sustainable gastrointestinal nematode control by European dairy cattle farmers : a multi-country cross-sectional study Universiteit Gent
A statistical framework for calculating prospective sample sizes and classifying efficacy results for faecal egg count reduction tests in ruminants, horses and swine Universiteit Gent
Report of three patients with extensive neurocysticercosis in rural southern Tanzania: neurological, serological and neuroradiological findings Instituut voor Tropische Geneeskunde Universiteit Gent
BACKGROUND: Neurocysticercosis (NCC) is common in eastern Africa, but disease presentation varies considerably. Most patients have single or few NCC-typical lesions in their brain but some present with a large number of lesions. We present three patients with positive antibody-based serology for Taenia solium cysticercosis screened at the Vwawa district hospital, Mbozi district, southern Tanzania, in whom extensive NCC was confirmed by ...
Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study Instituut voor Tropische Geneeskunde Universiteit Gent
PURPOSE: Neurocysticercosis is common in regions endemic for Taenia solium. Active-stage neurocysticercosis can be treated with antiparasitic medication, but so far no study on efficacy and safety has been conducted in Africa.
METHODS: We conducted a prospective cohort study on treatment of neurocysticercosis in Tanzania between August 2018 and January 2022. Patients were initially treated with albendazole (15 mg/kg/d) for 10 days and ...